You Can Reduce the Chances of Death From Heart Disease By Taking Specific “3-in-1” Pill

You Can Reduce the Chances of Death From Heart Disease By Taking Specific “3-in-1” Pill

The stats show that once every 34 seconds in the US, a person dies from cardiovascular disease. Only in 2020, about 697,000 souls from the same country left this world because of heart disease, hopefully for a better one. 

According to the New York Post, a new discovery presented at the European Society of Cardiology Congress (ESC 2022) in Barcelona has the Trinomia drug under the spotlight. It’s a heart medication and a polypill developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer. Trinomia has been shown to be able to reduce the chances of a second adverse cardiovascular event in the case of people who have already dealt with a heart attack.

Trinomia consists of three meds

The Trinomia drug is a 3-in-1 compound, as it consists of three meds: 100g of aspirin, 2.5, 5, or 10 g of ramipril, and 20 or 40mg of atorvastatin.

Oscar Pérez, who is the marketing chief and business development officer at Ferrer, explained as the New York Post quotes:

The 33% reduction in cardiovascular mortality demonstrates the efficacy of treatment with Trinomia compared to standard treatment.

Dr. Valentin Fuster was the one who led the trial, and he explained, as the same source quotes, that the results prove “for the first time that the polypill — which contains aspirin, ramipril and atorvastatin — achieves clinically relevant reductions in the recurrent cardiovascular events among people who have recovered from a previous heart attack.” 

Dr. José María Castellano, M.D, is the first author of the study, and he explained, as the New York Post also quotes:

Adherence to treatment after an acute myocardial infarction is essential for effective secondary prevention.

The polypill, [which is] a very simple strategy that combines three essential treatments for this type of patient, has proved its worth … The improved adherence means that these patients are receiving better treatment and therefore have a lower risk of recurrent cardiovascular events.

The new research was published in the New England Journal of Medicine.


Even since he was a child, Cristian was staring curiously at the stars, wondering about the Universe and our place in it. Today he's seeing his dream come true by writing about the latest news in astronomy. Cristian is also glad to be covering health and other science topics, having significant experience in writing about such fields.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.